Trifluoperazine
Back to search| Scientific Name: | Trifluoperazine |
| Brand Name: | Not Available |
| Company Owner: | Glaxosmithkline, Sandoz inc, Wockhardt eu operations (swiss) ag, Duramed pharmaceuticals inc sub barr laboratories inc, Ivax pharmaceuticals inc, Mylan pharmaceuticals inc, Watson laboratories inc |
| Mechanism Of Action | Trifluoperazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis. |
| Description of the Drug: | Trifluoperazine is a phenothiazine used to treat depression, anxiety, and agitation. |
| Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00831
